According to a ligand-based prediction model, 8 different hit compounds from the plant (kaempferol 3-O-β-D-Xyloside, myricetin, quercetin-3-O- β-D-arabinofuranoside, delphinidin, gallic acid, quercetin-3-O-D-galactopyranoside, (+) catechin, protocatechuic acid, epigallocatechin, naringenin and (−) epicatechin) have potential action against glutamine-fructose-6-phosphate aminotransferase 1 (GFAT1) and dipeptidyl peptidase-4 (DPP-4), two promising therapeutic targets for DM management [80]. This evidence concerns the gene DPP4 and diabetes mellitus.